These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32889244)

  • 1. Prognosis prediction signature of seven immune genes based on HPV status in cervical cancer.
    Xia Q; Jin H; Zhang X; Yan W; Meng D; Ding B; Cao J; Li D; Wang S
    Int Immunopharmacol; 2020 Nov; 88():106935. PubMed ID: 32889244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of High-Risk Human Papillomavirus-Related Long Non-Coding RNAs in the Prognosis of Cervical Squamous Cell Carcinoma.
    Cheng Y; Yang S; Shen Y; Ding B; Wu W; Zhang Y; Liang G
    DNA Cell Biol; 2020 Apr; 39(4):645-653. PubMed ID: 32045269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel prognostic prediction model based on seven immune-related RNAs for predicting overall survival of patients in early cervical squamous cell carcinoma.
    Qin R; Cao L; Ye C; Wang J; Sun Z
    BMC Med Genomics; 2021 Feb; 14(1):49. PubMed ID: 33588862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prognostic signature based on immune-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
    Liu J; Wu Z; Wang Y; Nie S; Sun R; Yang J; Cheng W
    Int Immunopharmacol; 2020 Nov; 88():106884. PubMed ID: 32795900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 29 immune-related genes pairs signature predict the prognosis of cervical cancer patients.
    Nie H; Bu F; Xu J; Li T; Huang J
    Sci Rep; 2020 Aug; 10(1):14152. PubMed ID: 32843657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Complete Validation of Prognostic Gene Signatures for Human Papillomavirus-Associated Cancers: Integrated Approach Covering Different Anatomical Locations.
    Kwon EJ; Ha M; Jang JY; Kim YH
    J Virol; 2021 Feb; 95(6):. PubMed ID: 33361419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of HPV-mediated immune alterations in cervical cancer.
    Chen L; Luan S; Xia B; Liu Y; Gao Y; Yu H; Mu Q; Zhang P; Zhang W; Zhang S; Wei G; Yang M; Li K
    Gynecol Oncol; 2018 May; 149(2):248-255. PubMed ID: 29572030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-related methylation-based reclassification and risk stratification of cervical cancer.
    Yang S; Wu Y; Wang S; Xu P; Deng Y; Wang M; Liu K; Tian T; Zhu Y; Li N; Zhou L; Dai Z; Kang H
    Mol Oncol; 2020 Sep; 14(9):2124-2141. PubMed ID: 32408396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus 16 infection alters the Toll-like receptors and downstream signaling cascade: A plausible early event in cervical squamous cell carcinoma development.
    Guleria C; Suri V; Kapoor R; Minz RW; Aggarwal R
    Gynecol Oncol; 2019 Oct; 155(1):151-160. PubMed ID: 31375269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of an immune-based mRNA-lncRNA signature for overall survival in cervical squamous cell carcinoma.
    Mao Y; Chen R; Xia M; Guo P; Zeng F; Huang J; He M
    Future Oncol; 2021 Jun; 17(18):2365-2380. PubMed ID: 33724869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Utility of a metabolic-associated nomogram to predict the recurrence-free survival of stage I cervical cancer.
    Zhang Y; Lu H; Zhang J; Wang S
    Future Oncol; 2021 Apr; 17(11):1325-1337. PubMed ID: 33631974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenomic Identification for Predicting the Prognosis of Cervical Cancer Patients.
    Wang Q; Vattai A; Vilsmaier T; Kaltofen T; Steger A; Mayr D; Mahner S; Jeschke U; Hildegard Heidegger H
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33671013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk allelic load in Th2 and Th3 cytokines genes as biomarker of susceptibility to HPV-16 positive cervical cancer: a case control study.
    Torres-Poveda K; Burguete-García AI; Bahena-Román M; Méndez-Martínez R; Zurita-Díaz MA; López-Estrada G; Delgado-Romero K; Peralta-Zaragoza O; Bermúdez-Morales VH; Cantú D; García-Carrancá A; Madrid-Marina V
    BMC Cancer; 2016 May; 16():330. PubMed ID: 27220278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new marker based on risk stratification of human papillomavirus DNA and tumor size to predict survival of locally advanced cervical cancer.
    Huang Y; He Q; Xu K; Zhou J; Yin J; Li F; Feng M; Lang J
    Int J Gynecol Cancer; 2019 Mar; 29(3):459-465. PubMed ID: 30733276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis.
    Jung AC; Guihard S; Krugell S; Ledrappier S; Brochot A; Dalstein V; Job S; de Reynies A; Noël G; Wasylyk B; Clavel C; Abecassis J
    Int J Cancer; 2013 Jan; 132(2):E26-36. PubMed ID: 22890882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A five-mRNA signature associated with post-translational modifications can better predict recurrence and survival in cervical cancer.
    Ju M; Qi A; Bi J; Zhao L; Jiang L; Zhang Q; Wei Q; Guan Q; Li X; Wang L; Wei M; Zhao L
    J Cell Mol Med; 2020 Jun; 24(11):6283-6297. PubMed ID: 32306508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune Signature-Based Subtypes of Cervical Squamous Cell Carcinoma Tightly Associated with Human Papillomavirus Type 16 Expression, Molecular Features, and Clinical Outcome.
    Lu X; Jiang L; Zhang L; Zhu Y; Hu W; Wang J; Ruan X; Xu Z; Meng X; Gao J; Su X; Yan F
    Neoplasia; 2019 Jun; 21(6):591-601. PubMed ID: 31055200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Immune-Gene-Based Classifier Predicts Prognosis in Patients With Cervical Squamous Cell Carcinoma.
    Yang H; Han X; Hao Z
    Front Mol Biosci; 2021; 8():679474. PubMed ID: 34291084
    [No Abstract]   [Full Text] [Related]  

  • 19. Human papillomavirus-stratified analysis of the prognostic role of miR-21 in oral cavity and oropharyngeal squamous cell carcinoma.
    Ko YH; Won HS; Sun DS; An HJ; Jeon EK; Kim MS; Lee HH; Kang JH; Jung CK
    Pathol Int; 2014 Oct; 64(10):499-507. PubMed ID: 25236707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures.
    Peng L; Hayatullah G; Zhou H; Chang S; Liu L; Qiu H; Duan X; Han L
    PLoS One; 2021; 16(4):e0249374. PubMed ID: 33901225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.